Ampio Pharma (AMPE) CEO Issues Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Ampio Pharmaceuticals Issues Letter to Stockholders
August 3, 2022 8:30 AM EDTENGLEWOOD, Colo., Aug. 3, 2022 /PRNewswire/ --Â Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive Officer, Mike Martino.



